MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients

Chen, XM; Zhou, J; Wu, LL; Zhu, X; Deng, H

Zhu, X; Deng, H (通讯作者)，Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 3, 600 Tianhe Rd, Guangzhou, Peoples R China.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022; 15 (): 673

Abstract

Purpose: Chronic hepatitis B (CHB) and metabolic associated fatty liver disease (MAFLD) are both important public health problems. The effect of conco......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索